Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.19% |
| 2 | Financials | 11.87% |
| 3 | Industrials | 10.26% |
| 4 | Energy | 9.33% |
| 5 | Technology | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
GSK
GSK
$103B
| $77.1M | 0.16% |
1,601,309
+1,021,508
| +176% | +$50.5M |
|
152
Cboe Global Markets
CBOE
$29.8B
| $76.7M | 0.16% |
1,038,436
+211,148
| +26% | +$14.5M |
|
|
PRAH
153
DELISTED
PRA Health Sciences, Inc.
PRAH
| $76.7M | 0.16% |
1,391,995
+703,301
| +102% | +$38.6M |
|
|
MON
154
DELISTED
Monsanto Co
MON
| $76.2M | 0.16% |
724,486
-870,075
| -55% | -$89.2M |
|
|
CIT
155
DELISTED
CIT Group Inc.
CIT
| $75.4M | 0.16% |
1,766,623
+1,562,424
| +765% | +$61.5M |
|
156
Eastman Chemical
EMN
$7.8B
| $74.4M | 0.16% |
988,645
+430,461
| +77% | +$31.1M |
|
|
HRC
157
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $73.8M | 0.15% |
1,314,388
+512,788
| +64% | +$29.1M |
|
|
FMSA
158
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $73.7M | 0.15% |
6,252,492
+575,606
| +10% | +$5.32M |
|
159
Colgate-Palmolive
CL
$72.6B
| $73.4M | 0.15% |
1,121,678
+415,950
| +59% | +$28.5M |
|
160
Moody's
MCO
$81.7B
| $73.4M | 0.15% |
778,483
+725,544
| +1,371% | +$73.2M |
|
|
NFX
161
DELISTED
Newfield Exploration
NFX
| $73.4M | 0.15% |
1,811,764
+1,194,070
| +193% | +$50.7M |
|
162
Xerox
XRX
$337M
| $73.3M | 0.15% |
3,184,525
+2,464,941
| +343% | +$61.4M |
|
163
Best Buy
BBY
$18B
| $73.1M | 0.15% |
1,712,833
-110,769
| -6% | -$4.71M |
|
164
Honeywell
HON
$77.1B
| $73M | 0.15% |
697,952
+453,893
| +186% | +$46.2M |
|
165
Viasat
VSAT
$9.79B
| $72.9M | 0.15% |
1,101,247
+599,402
| +119% | +$43M |
|
|
HR
166
DELISTED
Healthcare Realty Trust Incorporated
HR
| $72.9M | 0.15% |
2,403,480
+37,088
| +2% | +$1.13M |
|
167
Ovintiv
OVV
$17.5B
| $72.7M | 0.15% |
1,238,602
-2,625,603
| -68% | -$150M |
|
|
SYNH
168
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $72.2M | 0.15% |
1,372,445
+898,493
| +190% | +$43.5M |
|
|
BDN
169
Brandywine Realty Trust
BDN
$551M
| $71.7M | 0.15% |
4,342,637
+3,310,742
| +321% | +$50.7M |
|
170
Targa Resources
TRGP
$60.4B
| $71.5M | 0.15% |
1,274,564
-941,702
| -42% | -$47.6M |
|
|
BERY
171
DELISTED
Berry Global Group, Inc.
BERY
| $70.5M | 0.15% |
1,574,921
+754,770
| +92% | +$32.3M |
|
172
CubeSmart
CUBE
$9.53B
| $70.2M | 0.15% |
2,623,014
+1,935,556
| +282% | +$49.6M |
|
|
QGENF
173
DELISTED
QIAGEN NV
QGENF
| $69.6M | 0.15% |
2,482,273
-224,024
| -8% | -$6.28M |
|
174
Zoetis
ZTS
$31.6B
| $69.2M | 0.14% |
1,292,515
-431,755
| -25% | -$22M |
|
175
Hubbell
HUBB
$25.7B
| $68.9M | 0.14% |
590,297
+376,149
| +176% | +$41.3M |
|
Similar funds
Millennium Management's Q4 2016 Portfolio in Review
As of Q4 2016, Millennium Management held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Millennium Management withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Financials and Industrials.
Against the trend, Millennium Management opened a new position in Target worth $175M.
- Millennium Management's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Millennium Management added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Millennium Management's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Millennium Management fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Millennium Management's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Millennium Management opened 858 new positions and closed 801 in Q4 2016.
- Millennium Management's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.